2Pamukkale University, Department of Internal Medicine, Denizli, Turkey
3Pamukkale University, Department of Cardiology, Denizli, Turkey
4Pamukkale University, Department of Intensıve Care Unit, Denizli, Turkey
Abstract
The novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) related coronavirus disease 2019 (COVID-19) has been declared as a global pandemic by the World Health Organization. Brugada Syndrome (BrS) has been shown to occur spontaneously in patients with a viral infection, and the fever is the culprit trigger in the underlying mechanism. Herein, we described a patient who presented with syncope and Brugada-type electrocardiogram (ECG) pattern and diagnosed with COVID-19 pneumonia. The patient was taken to the intensive care unit for continuous ECG recording and monitoring. Favipiravir, low molecular weight heparin, high flow oxygen therapy, and antipyretic therapy were initiated. Brugada-type ECG pattern was disappeared with a resolution of fever. ECG findings of BrS may occur during fever and may lead to life-threatening arrhythmic events in unknown subjects. This clinical condition may require a subcutaneous implantable cardioverter-defibrillator in some patients. ECG should be a part of clinical evaluation in patients with COVID-19 even though without syncope.